Profile change history

What changed for Peginesatide?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Peginesatide identity.

34Total events
34Record additions
0Version changes
10Cited source years

Collection chronology

Evidence added to PeptideScanner

Browse all 34 connected records →

Showing the latest 34 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 17, 2026.

Record added

Federal Register notice 2011-27327

The Federal Register published notice 2011-27327, attributed to FDA and its parent HHS department, on 2011-10-24. Its official title is “Oncologic Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Peginesatide.

PeptideScanner change date
November 17, 2026
Cited source date
October 24, 2011
Evidence lane
Regulatory
Record added

Federal Register notice 2014-11523

The Federal Register published notice 2014-11523, attributed to FDA and its parent HHS department, on 2014-05-20. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; OMONTYS,” and PeptideScanner's exact reviewed identity mapping connects the document to Peginesatide.

PeptideScanner change date
November 17, 2026
Cited source date
May 20, 2014
Evidence lane
Regulatory
Record added

Federal Register notice 2019-02146

The Federal Register published notice 2019-02146, attributed to FDA and its parent HHS department, on 2019-02-13. Its official title is “Takeda Pharmaceuticals U.S.A., Inc.; Withdrawal of Approval of a New Drug Application for OMONTYS (peginesatide) Injection,” and PeptideScanner's exact reviewed identity mapping connects the document to Peginesatide.

PeptideScanner change date
November 17, 2026
Cited source date
February 13, 2019
Evidence lane
Regulatory
Record added

ClinicalTrials.gov record NCT00097747

PeptideScanner retained ClinicalTrials.gov record NCT00097747 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-12-21, and PeptideScanner's reviewed identity mapping was peginesatide.

PeptideScanner change date
November 16, 2026
Cited source date
December 21, 2012
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00228436

PeptideScanner retained ClinicalTrials.gov record NCT00228436 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-12-21, and PeptideScanner's reviewed identity mapping was peginesatide.

PeptideScanner change date
November 16, 2026
Cited source date
December 21, 2012
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00228449

PeptideScanner retained ClinicalTrials.gov record NCT00228449 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-12-21, and PeptideScanner's reviewed identity mapping was peginesatide.

PeptideScanner change date
November 16, 2026
Cited source date
December 21, 2012
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00272662

PeptideScanner retained ClinicalTrials.gov record NCT00272662 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-12-21, and PeptideScanner's reviewed identity mapping was peginesatide.

PeptideScanner change date
November 16, 2026
Cited source date
December 21, 2012
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00314795

PeptideScanner retained ClinicalTrials.gov record NCT00314795 at 2026-11-16T17:45:11.119Z. Its registry update date was 2019-03-14, and PeptideScanner's reviewed identity mapping was peginesatide.

PeptideScanner change date
November 16, 2026
Cited source date
March 14, 2019
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00434330

PeptideScanner retained ClinicalTrials.gov record NCT00434330 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-06-29, and PeptideScanner's reviewed identity mapping was peginesatide.

PeptideScanner change date
November 16, 2026
Cited source date
June 29, 2012
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00597584

PeptideScanner retained ClinicalTrials.gov record NCT00597584 at 2026-11-16T17:45:11.119Z. Its registry update date was 2013-03-08, and PeptideScanner's reviewed identity mapping was peginesatide.

PeptideScanner change date
November 16, 2026
Cited source date
March 8, 2013
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00597753

PeptideScanner retained ClinicalTrials.gov record NCT00597753 at 2026-11-16T17:45:11.119Z. Its registry update date was 2013-02-12, and PeptideScanner's reviewed identity mapping was peginesatide.

PeptideScanner change date
November 16, 2026
Cited source date
February 12, 2013
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00598273

PeptideScanner retained ClinicalTrials.gov record NCT00598273 at 2026-11-16T17:45:11.119Z. Its registry update date was 2013-02-12, and PeptideScanner's reviewed identity mapping was peginesatide.

PeptideScanner change date
November 16, 2026
Cited source date
February 12, 2013
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00598442

PeptideScanner retained ClinicalTrials.gov record NCT00598442 at 2026-11-16T17:45:11.119Z. Its registry update date was 2013-02-12, and PeptideScanner's reviewed identity mapping was peginesatide.

PeptideScanner change date
November 16, 2026
Cited source date
February 12, 2013
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00680043

PeptideScanner retained ClinicalTrials.gov record NCT00680043 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-06-29, and PeptideScanner's reviewed identity mapping was peginesatide.

PeptideScanner change date
November 16, 2026
Cited source date
June 29, 2012
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00752609

PeptideScanner retained ClinicalTrials.gov record NCT00752609 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-07-27, and PeptideScanner's reviewed identity mapping was peginesatide.

PeptideScanner change date
November 16, 2026
Cited source date
July 27, 2012
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00752791

PeptideScanner retained ClinicalTrials.gov record NCT00752791 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-08-15, and PeptideScanner's reviewed identity mapping was peginesatide.

PeptideScanner change date
November 16, 2026
Cited source date
August 15, 2012
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01478971

PeptideScanner retained ClinicalTrials.gov record NCT01478971 at 2026-11-16T17:45:11.119Z. Its registry update date was 2016-09-20, and PeptideScanner's reviewed identity mapping was peginesatide.

PeptideScanner change date
November 16, 2026
Cited source date
September 20, 2016
Evidence lane
Clinical trials
Record added

Methods for detection and confirmation of Hematide™/peginesatide in anti-doping samples.

PubMed lists PMID 21816551 in Forensic science international as Journal Article, with publication-date metadata of 2011-08-03 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 16, 2017
Evidence lane
Literature metadata
Record added

Development and validation of a mass spectrometric detection method of peginesatide in dried blood spots for sports drug testing.

PubMed lists PMID 22592927 in Analytical and bioanalytical chemistry as Journal Article, Research Support, Non-U.S. Gov't, Validation Study, with publication-date metadata of 2012-05-17 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
December 10, 2019
Evidence lane
Literature metadata
Record added

Peginesatide (Omontys) for anemia in chronic kidney failure.

PubMed lists PMID 22683926 in The Medical letter on drugs and therapeutics as Journal Article, with publication-date metadata of 2012-06-11 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
January 28, 2026
Evidence lane
Literature metadata
Record added

Peginesatide for the treatment of anemia in the nephrology setting.

PubMed lists PMID 22745925 in Drugs of today (Barcelona, Spain : 1998) as Journal Article, with publication-date metadata of 2012-06 (month precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
December 1, 2018
Evidence lane
Literature metadata
Record added

Peginesatide acetate, axitinib, and pertuzumab.

PubMed lists PMID 23023854 in Journal of the American Pharmacists Association : JAPhA as Journal Article, Review, with publication-date metadata of 2012 Sep-Oct (source-text precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 9, 2026
Evidence lane
Literature metadata
Record added

Peginesatide for maintenance treatment of anemia in hemodialysis and nondialysis patients previously treated with darbepoetin alfa.

PubMed lists PMID 23243269 in Clinical journal of the American Society of Nephrology : CJASN as Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2012-12-14 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
October 21, 2021
Evidence lane
Literature metadata
Record added

Peginesatide in patients with anemia undergoing hemodialysis.

PubMed lists PMID 23343061 in The New England journal of medicine as Clinical Trial, Phase III, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, and 1 more PubMed publication type, with publication-date metadata of 2013-01-24 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
May 18, 2026
Evidence lane
Literature metadata
Record added

Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis.

PubMed lists PMID 23343062 in The New England journal of medicine as Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-01-24 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
May 18, 2026
Evidence lane
Literature metadata
Record added

Peginesatide for anemia in chronic kidney disease.

PubMed lists PMID 23594010 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2013-04-18 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
December 2, 2018
Evidence lane
Literature metadata
Record added

Peginesatide for anemia in chronic kidney disease.

PubMed lists PMID 23594011 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2013-04-18 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
December 2, 2018
Evidence lane
Literature metadata
Record added

Peginesatide as a new approach for treating anemia of CKD patient: is it like a falling star?

PubMed lists PMID 23675762 in Expert opinion on pharmacotherapy as Editorial, with publication-date metadata of 2013-05-16 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 16, 2017
Evidence lane
Literature metadata
Record added

On peginesatide and anemia treatment in CKD.

PubMed lists PMID 23810692 in American journal of kidney diseases : the official journal of the National Kidney Foundation as Editorial, Comment, with publication-date metadata of 2013-06-28 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
December 2, 2018
Evidence lane
Literature metadata
Record added

Managing dialysis patients who develop anemia caused by chronic kidney disease: focus on peginesatide.

PubMed lists PMID 24023516 in International journal of nanomedicine as Journal Article, Review, with publication-date metadata of 2013-08-26 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
October 21, 2021
Evidence lane
Literature metadata
Record added

Peginesatide to Manage Anemia in Chronic Kidney Disease Patients on Peritoneal Dialysis.

PubMed lists PMID 24584613 in Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis as Clinical Trial, Clinical Trial, Phase II, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2014-03-01 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
October 21, 2021
Evidence lane
Literature metadata
Record added

Watch out for a revival of peginesatide in sports.

PubMed lists PMID 27279382 in Drug testing and analysis as Journal Article, with publication-date metadata of 2016-06-09 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 16, 2017
Evidence lane
Literature metadata
Record added

Peginesatide for the treatment of anemia due to chronic kidney disease - an unfulfilled promise.

PubMed lists PMID 27551882 in Expert opinion on drug safety as Comparative Study, Journal Article, Review, with publication-date metadata of 2016-08-23 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 13, 2018
Evidence lane
Literature metadata